Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-26-063825
Filing Date
2026-06-02
Accepted
2026-06-02 09:04:34
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea029311505-424b3_kazia.htm 424B3 128637
2 GRAPHIC ea029311505_img1.jpg GRAPHIC 11008
3 GRAPHIC ea029311505_img2.jpg GRAPHIC 4293
  Complete submission text file 0001213900-26-063825.txt   151292
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-292303 | Film No.: 261053822
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)